EMA Management Board highlights key outcomes from March 2026 meeting

18th March 2026

Summary:
The European Medicines Agency (EMA) has published highlights from its Management Board meeting held in March 2026, outlining key discussions and decisions on regulatory, strategic and organisational priorities. Topics included progress on the implementation of the EU pharmaceutical legislation, updates on preparedness for public health emergencies and ongoing efforts to strengthen the EU medicines regulatory network. The Board also reviewed developments in areas such as digital transformation, data use and international collaboration, alongside organisational matters including budget and governance. The updates reflect EMA’s continued focus on enhancing regulatory efficiency, supporting innovation and ensuring the availability of safe and effective medicines across the EU.

Link: https://www.ema.europa.eu/en/news/ema-management-board-highlights-march-2026-meeting

Back to Recent News